ascopubs.org

TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated ...

First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study This cohort study included ...